Speciality :
Consultant medical oncologist
Double Board Certified in Radiation Oncology & Medical Oncology
Personal Info
Dr. Hemanth Muttuluri is a seasoned medical oncologist with over 9 years of experience in treating solid tumors, hematolymphoid malignancies, and rare clinical scenarios. He is committed to advancing oncological care through innovative treatment approaches and dedicated research.
As a consultant medical oncologist at Indian Red Cross Society Cancer Hospital, Nellore, India, Dr. Muttuluri provides comprehensive care to patients with various types of cancer.
Education :
- 2019-2022: Residency (DM) in Medical Oncology, Tata Memorial Hospital, Homi Baba National Institute, Mumbai, India
- 2014-2018: Residency (MD) in Radiation Oncology, SVIMS, Tirupati, India
- 2006-2011: MBBS, Narayana Medical College, Dr. NTR University of Health Sciences, Nellore, India
Experience :
- 2023-Present: Consultant Medical Oncologist, Indian Red Cross Society Cancer Hospital, Nellore.
- 2022-2023 -Assistant Professor – Homi Baba Cancer Hospital and Research Centre, Punjab.
- 2018-2019 – Specialist Registrar -Department of Radiation Oncology, Tirupati.
- 2011-2012 -Intern -Narayana Medical college, Dr. NTR University of Health Sciences, Nellore.
Professional Skills
Specialized in medical and radiation oncology with a focus on solid tumors, hematolymphoid malignancies and rare clinical scenarios. Committed to advancing oncological care through innovative treatment approaches and dedicated research.
100
%
Advanced Oncology
100
%
Innovative treatment
100
%
Clinical Research
Invited Presentations at Conferences:
- 21-23 January 2022: Phase III Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral Cancer” in 8th national annual conference of ISMPOCON 2022.
- 3-6 July 2022: Outcomes and adverse events of low dose nivolumab in platinum refractory head and neck cancers in 2022 ASCO Annual meeting, Chicago.
- 10-12 December 2021: An Audit of systemic therapy in medullary carcinoma of thyroid” in 21″ Annual Conference Foundation for Head and Neck Oncology (FHNO) 2021, Kerala.
- 29-31 January 2016: A retrospective study of epidemiological and clinical profile of nasopharyngeal carcinoma in a tertiary care cancer centre in Andhra Pradesh, Young Radiation Oncology Conference (YROC), at Rajkot.
- 9-12 November 2017: [No information provided]
Lectures to non-physician health care professionals:
- For radiation technology students on clinical oncology while working as senior registrar in radiation oncology department in SVIMS, Tirupathi.
- For trial coordinators on tyrosine kinase inhibitors in the month of December 2023 while working as assistant professor in the dept of oncology in Tata memorial hospital.
- For nursing students on emergencies in oncology while working as assistant professor in the dept of oncology in Tata memorial hospital.
SPECIALTY CERTIFICATE, LICENSURE AND OTHER CERTIFICATES
- Aug 2023: Medical Oncology Licensure from Andhra Pradesh Medical Council, India.
- Dec 2019: Good Clinical Practice basic and Advanced Course from Tata memorial center.
- Jul 2019: Radiation Oncology licensure from Andhra Pradesh Medical Council.
- 2018: Basic Life Support by American Heart Association, Advanced Cardiac Life Support by American Heart Association.
- Mar 2012: Ethics awareness program for interns/post graduates by Narayana medical college hospital in association with Andhra Pradesh medical Council.
Conferences
- 22nd April 2023: Palliative care in oncology held at Homi Bhabha cancer hospital, Chandigarh.
- 11th February 2023: Clinical Updates in Breast & Hematological Malignancies, Updates from ASH 2022 & SABCS 2022 held in Chandigarh.
- 6th February 2023: Prostate cancer diagnosis and management conducted by AstraZeneca Oncology forum.
- 20th June 2023: Early nutrition intervention in Oncology held by Signatura Nutrition.
- 26th July 2023: Updates in lung cancer diagnosis and management and Avelumab in Bladder cancer held by AstraZeneca.
- 30th December 2023: Darolutamide in Prostate cancer ARASENS summary held by Bayers.
- etc
Webinars
- 25th October 2022: Updates in the management of Her 2 positive metastatic breast cancer held by Cipla Oncology forum.
- 19th November 2022: Advances & Emerging Data in HR+ Breast cancer at Cipla Expert forum.
- 17th January 2023: Case based discussion in metastatic Hepatocellular carcinoma (HCC) at Expert forum: contemporary management of HCC conducted by Cipla.
- 3rd February 2023: Key insights on Olaparib in Ovarian cancer, Pancreatic cancer, Breast cancer and Prostate cancer held by Natco oncology forum.
- 13th April 2023: Lorlatinib in Lung Cancer at “Lungevity” webinar held by Pfizer.
- 25th May 2023: Cipla Expert forum meet in management of ovarian cancer.
- etc
February 2022.
Won first prize
Won first prize in the quiz on "radiation oncology updates" in the conference held by Association of radiation oncologists (AROI) Andhra Pradesh state chapter in the month of